Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Lee Website

Kyung S. Lee, Ph.D.

Selected Publications

1)  Zou J, Rezvani K, Wang H, Lee KS, Zhang D.
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress.
Cell Cycle. 12, 2013.
2)  Murugan RN, Park JE, Lim D, Ahn M, Cheong C, Kwon T, Nam KY, Choi SH, Kim BY, Yoon DY, Yaffe MB, Yu DY, Lee KS, Bang JK.
Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.
Bioorg. Med. Chem. 21: 2623-34, 2013.
3)  Chang J, Seo SG, Lee KH, Nagashima K, Bang JK, Kim BY, Erikson RL, Lee KW, Lee HJ, Park JE, Lee KS.
Essential role of Cenexin1, but not Odf2, in ciliogenesis.
Cell Cycle. 12: 655-62, 2013.
4)  González-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM.
Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling.
J. Biol. Chem. 288: 9428-37, 2013.
5)  He L, Lee J, Jang JH, Sakchaisri K, Hwang J, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, Soung NK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY.
Osteoporosis regulation by salubrinal through eIF2a mediated differentiation of osteoclast and osteoblast.
Cell. Signal. 25: 552-60, 2013.
6)  Kim SO, Sakchaisri K, Thimmegowda NR, N R T, Soung NK, Jang JH, Kim YS, Lee KS, Kwon YT, Asami Y, Ahn JS, Erikson RL, Kim BY.
STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.
PLoS ONE. 8: e53908, 2013.
7)  Qian W, Park J, Liu F, Lee KS, Burke TR.
Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.
Bioorg Med Chem. [Epub ahead of print], 2012.
8)  Lee KH, Johmura Y, Yu L, Park J, Gao Y, Bang JK, Zhou M, Veenstra TD, Yeon Kim B, Lee KS.
Identification of a novel Wnt5a-CK1ε-Dvl2-Plk1-mediated primary cilia disassembly pathway.
EMBO J. 31: 3104-17, 2012.
9)  Liu F, Park J, Qian W, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR.
Identification of High Affinity Polo-like Kinase 1 (Plk1) Polo-box Domain Binding Peptides Using Oxime-Based Diversification.
ACS Chem. Biol. 7: 805-10, 2012.
10)  Liu F, Park J, Qian W, Lim D, Scharow A, Berg T, Yaffe MB, Lee KS, Burke TR.
Peptoid-Peptide Hybrid Ligands Targeting the Polo Box Domain of Polo-Like Kinase 1.
Chembiochem. 13: 1291-6, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 9/12/2013.